Altura B M (1979) Sudden-death ischaemic heart disease and dietarymagnesium intake; is the target site coronary vascular smooth muscle?Med Hypothesis5: 843–848
2.
Boriss M N , Do L P (1988) Magnesium: a discussion of its role in the treatment of ventricular dysrhythmia . Crit Care Med16: 292–293
3.
Crawford M D , Gardner M J , Morris J N (1971) Cardiovascular disease and the mineral content of drinking water . Br Med Bull27: 21–24
4.
Imran N , Rampes H , Rosen S (2003) Antipsychotic induced prolongation of QTc interval treatment with magnesium . J Psychopharmacol17: 346–349
5.
Parker M , Gottleib S S , Blum M A (1987) Immediate and long term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patient with congestive heart failure . Am J Med82 (Suppl 3A): 4–10
6.
Rayssiguier Y (1984) Role of magnesium and potassium in the pathogenesis of arteriosclerosis . Magnesium3: 226–238
7.
Roden D M , Iansmith D H S (1987) Effects of low potassium and magnesium concentrations on isolated cardiac tissue . Am J Med82 (Suppl 3A): 18–23
8.
Ryan M F (1991) The role of magnesium in clinical biochemistry: an overview . Ann Clin Biochem28: 19–26
9.
Ryan M P , Brady H (1984) The role of magnesium in the prevention and control of hypertension . Ann Clin Res16: 81–89
10.
Seelig M S (1980) Magnesium deficiency in the pathogenesis of disease. Early roots of cardiovascular, skeletal and renal disease. Plenum Publishing, New York
11.
Seelig M S (1981) Magnesium requirements in human nutrition. 3rd International Symposium on Magnesium, Baden-Baden . Magnesium Bull3: 26–47
12.
Wang E T , Rude R K , Singer F R , Shaw S T Jr (1983) A high prevalence of hypomagnesaemia and hypermagnesaemia in hospitalised patients . Am J Clin Med79: 348–352